Latest news with #BarryButler
Yahoo
20-03-2025
- Business
- Yahoo
Eyenovia Shares Drop 14% Amid Betaliq Merger Talks
Eyenovia (EYEN, Financials) shares fell 14% to $1.44 as of 12:44 p.m. GMT-4 on Thursday after the company announced a non-binding letter of intent to merge with Betaliq, a clinical-stage pharmaceutical company specializing in glaucoma treatments. Warning! GuruFocus has detected 6 Warning Signs with EYEN. Combining Eyenovia's Optejet dispensing system with Betaliq's EyeSol medication delivery mechanism, the purchase would create a new publicly traded ophthalmology zero net cash upon closure, the acquisition values Betaliq at around $77 million and Eyenovia at almost $15 million. While Eyenovia owners would retain 16.3% on a fully diluted basis, Betaliq equity holders would control about 83.7% of the merged firms stated the acquisition is still under due consideration, board approvals, formal agreements, and financial contingency. About the timetable or completion of the merger, no guarantee was Betaliq's EyeSol technology seeks to increase bioavailability in glaucoma therapies, Eyenovia's Optejet platform is meant to improve ocular medication delivery. EyeSol has been licensed for use in FDA-approved eye care products, including MEIBOTM and VEVEYTM, the firms pointed said it would keep promoting its FDA-approved portfolio while looking for other in-licensing prospects to boost income. The business also is on schedule to submit for fourth quarter U.S. regulatory clearance of a user-filled Optejet the transaction is finalized, Eyenovia CEO Michael Rowe said the two technologies will be combined to enhance eye drug delivery. Barry Butler, CEO of Betaliq, said the mix offers a chance to increase glaucoma and other eye problem therapy Raymond James is representing Betaliq, Chardan is counseling Eyenovia on the offer. Eyenovia stated it does not intend to provide any updates unless a clear agreement is obtained or legal disclosure is mandated. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
12-03-2025
- Science
- Yahoo
Chicagohenge 2025: Everything you need to know
The Brief Chicagohenge occurs twice a year, aligning the sun with Chicago's east-west streets, creating a breathtaking view at sunrise and sunset. The event will be visible from March 20 to March 23, with peak viewing times during sunrise and sunset. CHICAGO - An extraordinary event marking the start of spring is set to light up Chicago next week, creating a must-see spectacle. Chicagohenge, a natural phenomenon, happens twice a year—once to welcome spring and again to bid summer farewell. Here's what you need to know to catch this stunning sight. The backstory During the event, the sun perfectly aligned with Chicago's east-west streets, creating a stunning view for residents. This alignment allows the sun to rise and set directly between the buildings, rather than being blocked by them. Timeline This year, you can catch it from March 20 to March 23 during sunrise or sunset: Thursday, March 20 – Sunrise at 6:53 a.m. | Sunset at 7:03 p.m. Friday, March 21 – Sunrise at 6:51 a.m. | Sunset at 7:04 p.m. Saturday, March 22 – Sunrise at 6:50 a.m. | Sunset at 7:05 p.m. Big picture view An equinox occurs when the Earth's equator aligns directly with the sun. This happens twice a year: in March for the Spring Equinox and in September for the Fall Equinox. During an equinox, both the Northern and Southern Hemispheres experience roughly 12 hours of daylight and 12 hours of darkness. The equinox also marks the official change of seasons. What we know The Adler Planetarium recommends heading to any of Chicago's east-west facing streets to view the phenomenon. Photographer Barry Butler, who has shared his expertise with us before, suggests Randolph, Madison, and Chicago streets as some of the best spots to catch the event. The Source Information in this article came from previous FOX 32 coverage, the Adler Planetarium and Photographer Barry Butler.
